Halozyme Therapeutics Inc (NAS:HALO)
$ 59.42 -0.19 (-0.32%) Market Cap: 7.56 Bil Enterprise Value: 8.43 Bil PE Ratio: 19.68 PB Ratio: 16.69 GF Score: 88/100

Halozyme Therapeutics Inc Annual Shareholders Meeting Transcript

May 05, 2021 / 03:00PM GMT
Release Date Price: $47.81 (-1.36%)
Helen I. Torley
Halozyme Therapeutics, Inc. - President, CEO & Director

Good morning. I am Helen Torley, President and Chief Executive Officer of Halozyme Therapeutics, and I'll be chairing this Annual Meeting of Shareholders.

I'd like to call the meeting to order. This meeting is being held pursuant to the notice of the annual meeting, which was mailed to all of the company's stockholders on or about March 26, 2021.

The polls are now open. At this time, any stockholders who are present and who would like to vote their shares at this meeting may do so by clicking the Voting button that's on your screen. Otherwise, the proxy holders will vote your shares as indicated on the proxy. (Operator Instructions)

Mas Matsuda, who is Halozyme's Senior Vice President, General Counsel and Corporate Secretary, has been appointed secretary for this meeting to record the minutes, and he has taken the oath to serve as Inspector of elections. Mr. Matsuda has previously provided Halozyme with a certificate indicating the number of votes represented by proxy at this meeting.

At

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot